Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-05-31 @ 8:32 AM
Study NCT ID:
NCT05432518
Status:
RECRUITING
Last Update Posted:
2025-04-25
First Post:
2022-06-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Trial for Treatment of Recurrent Glioblastoma
Sponsor:
AHS Cancer Control Alberta
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GBM-2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |